Analysis | Metabolite Name | Measured Value | Units | Cell Type | Stimulation |
---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | FUMARATE (CAS# 110-17-8); (M-H)- | 42862 | Peak area | PAK | TNF-alpha+IL-17A |
Reversed phase NEGATIVE ION MODE | FUMARATE (CAS# 110-17-8); (M-H)- | 45742 | Peak area | HAHA | Untreated |
Reversed phase NEGATIVE ION MODE | FUMARATE (CAS# 110-17-8); (M-H)- | 51445 | Peak area | HAHA | TNF-alpha+IL-17A |
Reversed phase NEGATIVE ION MODE | FUMARATE (CAS# 110-17-8); (M-H)- | 51755 | Peak area | PAK | IFN-G |
Reversed phase NEGATIVE ION MODE | FUMARATE (CAS# 110-17-8); (M-H)- | 52338 | Peak area | PAK | IL-17A |
Reversed phase NEGATIVE ION MODE | FUMARATE (CAS# 110-17-8); (M-H)- | 52845 | Peak area | HAHA | IL-17A |
Reversed phase NEGATIVE ION MODE | FUMARATE (CAS# 110-17-8); (M-H)- | 53290 | Peak area | HAHA | TNF-alpha |
Reversed phase NEGATIVE ION MODE | FUMARATE (CAS# 110-17-8); (M-H)- | 53724 | Peak area | BS4 | TNF-alpha+IL-17A |
Reversed phase NEGATIVE ION MODE | FUMARATE (CAS# 110-17-8); (M-H)- | 58542 | Peak area | BS4 | TNF-alpha |
Reversed phase NEGATIVE ION MODE | FUMARATE (CAS# 110-17-8); (M-H)- | 63317 | Peak area | PAK | TNF-alpha |
Reversed phase NEGATIVE ION MODE | FUMARATE (CAS# 110-17-8); (M-H)- | 65067 | Peak area | PAK | Untreated |
Reversed phase NEGATIVE ION MODE | FUMARATE (CAS# 110-17-8); (M-H)- | 67269 | Peak area | BS4 | IL-17A |
Reversed phase NEGATIVE ION MODE | FUMARATE (CAS# 110-17-8); (M-H)- | 70327 | Peak area | BS4 | IFN-G |
Reversed phase NEGATIVE ION MODE | FUMARATE (CAS# 110-17-8); (M-H)- | 72545 | Peak area | HAHA | IFN-G |
Reversed phase NEGATIVE ION MODE | FUMARATE (CAS# 110-17-8); (M-H)- | 88496 | Peak area | BS4 | Untreated |